NO313195B1 - Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse - Google Patents

Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse Download PDF

Info

Publication number
NO313195B1
NO313195B1 NO19972525A NO972525A NO313195B1 NO 313195 B1 NO313195 B1 NO 313195B1 NO 19972525 A NO19972525 A NO 19972525A NO 972525 A NO972525 A NO 972525A NO 313195 B1 NO313195 B1 NO 313195B1
Authority
NO
Norway
Prior art keywords
ethyl
antihistamine
benzimidazole derivatives
activity
new
Prior art date
Application number
NO19972525A
Other languages
English (en)
Norwegian (no)
Other versions
NO972525D0 (no
NO972525L (no
Inventor
Aurelio Orjales
Victor Rubio
Maravillas Bordell
Original Assignee
Espanola Prod Quimicos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Espanola Prod Quimicos filed Critical Espanola Prod Quimicos
Publication of NO972525D0 publication Critical patent/NO972525D0/no
Publication of NO972525L publication Critical patent/NO972525L/no
Publication of NO313195B1 publication Critical patent/NO313195B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19972525A 1996-06-04 1997-06-03 Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse NO313195B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (3)

Publication Number Publication Date
NO972525D0 NO972525D0 (no) 1997-06-03
NO972525L NO972525L (no) 1997-12-05
NO313195B1 true NO313195B1 (no) 2002-08-26

Family

ID=8295035

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19972525A NO313195B1 (no) 1996-06-04 1997-06-03 Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse
NO2011008C NO2011008I2 (no) 1996-06-04 2011-05-24 Bilastine eller et addisjonssalt derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2011008C NO2011008I2 (no) 1996-06-04 2011-05-24 Bilastine eller et addisjonssalt derav

Country Status (27)

Country Link
US (1) US5877187A (cs)
EP (1) EP0818454B1 (cs)
JP (1) JP4218991B2 (cs)
CN (1) CN1105716C (cs)
AR (1) AR008386A1 (cs)
AT (1) ATE264317T1 (cs)
AU (1) AU725700B2 (cs)
BR (1) BR9703276A (cs)
CA (1) CA2206754C (cs)
CZ (1) CZ289278B6 (cs)
DE (2) DE69728608T2 (cs)
DK (1) DK0818454T3 (cs)
ES (1) ES2124167B1 (cs)
FR (1) FR11C0023I2 (cs)
HR (1) HRP970307B1 (cs)
HU (1) HU227598B1 (cs)
IN (1) IN186319B (cs)
LU (1) LU91798I2 (cs)
MX (1) MXPA97004127A (cs)
NO (2) NO313195B1 (cs)
PL (1) PL188908B1 (cs)
PT (1) PT818454E (cs)
RU (1) RU2182150C2 (cs)
SI (1) SI0818454T1 (cs)
TR (1) TR199700464A2 (cs)
TW (1) TW438794B (cs)
ZA (1) ZA974893B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545009B1 (en) 1998-07-01 2003-04-08 Takeda Chemical Industries, Ltd. Retinoid-related receptor function regulating agent
HUP0200749A3 (en) 1998-11-27 2003-03-28 Basf Ag Substituted benzimidazoles and their use as parp inhibitors and process for their preparation
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
HU230032B1 (hu) * 2002-04-19 2015-05-28 Faes Farma, S.A Polimorf 4-{2-[4-[1-(2-etoxietil)-1H-benzimidazol-2-il]-1-piperidinil]etil}-alfa,alfa-dimetil-benzenoecetsav
CA2489128C (en) * 2002-06-13 2012-01-03 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101123903B1 (ko) * 2008-02-12 2012-03-23 주식회사유한양행 2-메틸-2'-페닐프로피온산 유도체의 제조 방법 및 이에 사용되는 신규한 중간체 화합물
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
CN105209122B (zh) * 2013-03-15 2018-07-17 赫尔克里士公司 组合物和制备具有提高的沉积性能的个人护理组合物的方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
WO2017017301A1 (es) * 2015-07-24 2017-02-02 Urquima, S.A Formas cristalinas de bilastina y procedimientos para su preparación
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
EP3452462A4 (en) * 2016-05-05 2019-10-23 MSN Laboratories Private Limited, R&D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
HUE053233T2 (hu) 2017-10-16 2021-06-28 Faes Farma Sa Bilasztint és mometanzont tartalmazó vizes készítmények
ES2864176T3 (es) 2017-12-18 2021-10-13 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua
EP3470062B1 (en) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate
MA51612B1 (fr) 2018-01-18 2021-06-30 Faes Farma Sa Compositions ophtalmiques comprenant de la bilastine, une bêta-cyclodextrine et au moins un agent gélifiant
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
EP4188339A1 (en) 2020-07-30 2023-06-07 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
EP4247331A1 (en) 2020-11-18 2023-09-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound
EP4267109A1 (en) 2020-12-23 2023-11-01 Noucor Health S.A. A non-micronized bilastine composition
WO2023156559A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration
WO2024224308A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine free of cyclodextrins
WO2024224326A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
CA2077897A1 (en) * 1990-04-13 1991-10-14 Robert G. Franz Substituted benzimidazoles
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
DK0701443T4 (da) * 1992-08-03 2000-12-18 Sepracor Inc Terfenadinmetabolitter og deres optisk rene isomerer til behandling af allergiske lidelser
AU699559B2 (en) * 1993-06-25 1998-12-10 Aventisub Ii Inc. Novel intermediates for the preparation of antihistaminic piperidine derivatives

Also Published As

Publication number Publication date
DE69728608D1 (de) 2004-05-19
ES2124167B1 (es) 1999-09-16
DE69728608T2 (de) 2005-04-21
US5877187A (en) 1999-03-02
IN186319B (cs) 2001-08-04
HRP970307B1 (en) 2002-02-28
CA2206754C (en) 2007-01-23
NO972525D0 (no) 1997-06-03
HU9700997D0 (en) 1997-07-28
CZ289278B6 (cs) 2001-12-12
RU2182150C2 (ru) 2002-05-10
TW438794B (en) 2001-06-07
PL320358A1 (en) 1997-12-08
SI0818454T1 (en) 2004-08-31
PL188908B1 (pl) 2005-05-31
CA2206754A1 (en) 1997-12-04
JP4218991B2 (ja) 2009-02-04
NO2011008I2 (no) 2012-05-14
EP0818454B1 (en) 2004-04-14
JPH1059961A (ja) 1998-03-03
FR11C0023I1 (cs) 2011-08-19
CZ172397A3 (en) 1997-12-17
NO972525L (no) 1997-12-05
HU227598B1 (en) 2011-09-28
TR199700464A3 (tr) 1997-12-21
NO2011008I1 (no) 2011-06-06
FR11C0023I2 (fr) 2012-03-16
ES2124167A1 (es) 1999-01-16
AR008386A1 (es) 2000-01-19
TR199700464A2 (xx) 1997-12-21
DE122011000006I1 (de) 2011-06-16
BR9703276A (pt) 2004-08-17
LU91798I2 (fr) 2011-05-23
AU2467297A (en) 1997-12-11
CN1105716C (zh) 2003-04-16
PT818454E (pt) 2004-08-31
CN1176964A (zh) 1998-03-25
EP0818454A1 (en) 1998-01-14
DK0818454T3 (da) 2004-07-12
HRP970307A2 (en) 1998-04-30
MXPA97004127A (es) 2005-07-25
AU725700B2 (en) 2000-10-19
ZA974893B (en) 1997-12-30
HUP9700997A1 (hu) 1999-09-28
ATE264317T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
NO313195B1 (no) Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse
DE60303381T2 (de) Neue indolylpiperidin-derivate als potente antihistaminische und antiallergische mittel
DE3005948C2 (cs)
DE69724108T2 (de) Isochinolinderivate und arzneimittel
DE3889133T2 (de) N-Heterocyclische N-(4-Piperidyl)-amide.
US5070087A (en) Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents
US20040044004A1 (en) Calcium channel inhibitors comprising benzhydril spaced from piperazine
EP2108648A1 (de) Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
CN114014796A (zh) 一类依巴斯汀的盐及其制备方法和应用
US5670509A (en) Tocolytic oxytocin receptor antagonists
US6391890B1 (en) Heterocyclic compounds
US20040266784A1 (en) Calcium channel inhibitors comprising benzhydril spaced from piperazine
DK167118B1 (da) Substituerede benzylphthalazinonderivater, fremgangsmaade til fremstilling deraf, laegemidler indeholdende derivaterne, samt anvendelse af derivaterne til fremstilling af laegemidler
DE2652201A1 (de) Benzisothiazolone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
IE59434B1 (en) n-substituted diphenylpiperidines
US5292745A (en) Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers
DE69404158T2 (de) 4-alkylamino-1-phenoxyalkyl piperidine als antiinflammatorische, antiallergische und immunomodulierende wirkstoffe
DE60009287T2 (de) Neuartige isoquinolin-derivate oder salze davon
AU688186B2 (en) (Thiophen-2-YL)-piperidin or tetrahydropyridin carboxamides
DE60118434T2 (de) Indolylpiperidinderivate als antihistaminische und antiallergische mittel
HU193719B (en) Process for producing antiarrithmic aryloxy-6-/aminoalkyl/-1-pirrolidine- and piperidine-carboxylic acids
WO1992006958A1 (en) 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
DD296923A5 (de) Piperidinylbenzimidazoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeperate
JPS624288A (ja) 新規なジアゼピノン化合物
NO153726B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(nafthalenyloxy)-piperidinderivater.

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: ZILAS; NAT. REG. NO/DATE: 09-6621 20110413; FIRST REG. NO/DATE: IS/1/10/002/01 20100923

Spc suppl protection certif: 2011008

Filing date: 20110524

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: ZILAS; NAT. REG. NO/DATE: 09-6621 20110413; FIRST REG. NO/DATE: IS/1/10/002/01 20100923

Spc suppl protection certif: 2011008

Filing date: 20110524

Extension date: 20220603

MK1K Patent expired
SPCX Expiry of an spc

Spc suppl protection certif: 2011008